News
Hosted on MSN3mon
1.5 billion people at risk: New tablet promises to battle parasitic worms with greater efficacyA new tablet that combines albendazole and ivermectin ... the EDCTP-funded STOP consortium tested a fixed-dose co-formulation (FDC) of albendazole and ivermectin in the ALIVE trial, which took ...
A new tablet combining albendazole and ivermectin is safe and more effective than albendazole alone in treating Trichuris trichiura and other soil-transmitted helminths (STH), according to a clinical ...
FDC launched two variants of Favipiravir in India at ₹55 per tablet under the brand names PiFLU and Favenza. Several other companies have launched the generic versions of Favipiravir so far in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results